Understand how pharmaceutical and biotechnology companies structure shared commercialization partnerships using intelligence from 523 real-world co-promotion and co-marketing deals.
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology 2016-2026 provides comprehensive intelligence on 523 co-promotion and co-marketing deals across the global life sciences industry.
Co-promotion and co-marketing agreements enable companies to combine commercial capabilities, share responsibility for promoting products and extend market reach while retaining defined rights and economic interests.
These arrangements can vary substantially in structure. Partners may divide responsibilities by product, customer group, geography or sales channel, while commercial economics can involve revenue sharing, profit sharing, royalties, supply arrangements and other negotiated mechanisms.
The report brings this activity together in one resource, enabling users to understand who is entering co-commercialization partnerships, how responsibilities and rights are allocated, what financial terms have been disclosed and how comparable agreements have been structured in practice.
Rather than simply identifying transactions, the report combines market-wide deal analysis with leading dealmaker intelligence, financial and commercial benchmarking, detailed transaction records and access to publicly available contract documents where available.
It provides a practical intelligence and benchmarking resource for business development, licensing, commercial strategy, alliance management, market access and legal teams involved in evaluating, structuring or negotiating co-promotion and co-marketing partnerships.
This provides real-world reference points for internal benchmarking, deal preparation and negotiation rather than relying on headline values or averages in isolation.
Identify prospective commercial partners, comparable transactions and relevant co-commercialization structures.
Commercial Strategy teams
Understand how companies share promotional and commercialization responsibilities and extend product reach through partnerships.
Companies Seeking Commercial Partners
Identify organizations with demonstrated experience in co-promotion and co-marketing within relevant therapeutic and product areas.
Alliance Management teams
Examine how commercial responsibilities, governance and ongoing partner obligations have been structured across comparable agreements.
Market Access and Regional Commercial teams
Understand how partnerships are being used to extend commercial reach across markets and territories.
Competitive and Market Intelligence teams
Track how competitors are using shared commercialization relationships and identify active co-promotion dealmakers.
Legal and Transaction teams
Review publicly available contracts and precedent agreement structures to support transaction preparation and negotiation.
The briefing applies the underlying co-promotion and co-marketing deal intelligence to the customer's own product, market or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective commercial partners, competitor activity, deal structures, commercial and financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology 2016-2026 provides comprehensive intelligence on 523 co-promotion and co-marketing deals across the global life sciences industry.
Co-promotion and co-marketing agreements enable companies to combine commercial capabilities, share responsibility for promoting products and extend market reach while retaining defined rights and economic interests.
These arrangements can vary substantially in structure. Partners may divide responsibilities by product, customer group, geography or sales channel, while commercial economics can involve revenue sharing, profit sharing, royalties, supply arrangements and other negotiated mechanisms.
The report brings this activity together in one resource, enabling users to understand who is entering co-commercialization partnerships, how responsibilities and rights are allocated, what financial terms have been disclosed and how comparable agreements have been structured in practice.
Rather than simply identifying transactions, the report combines market-wide deal analysis with leading dealmaker intelligence, financial and commercial benchmarking, detailed transaction records and access to publicly available contract documents where available.
It provides a practical intelligence and benchmarking resource for business development, licensing, commercial strategy, alliance management, market access and legal teams involved in evaluating, structuring or negotiating co-promotion and co-marketing partnerships.
Understand the co-promotion and co-marketing landscape
The report analyzes co-promotion and co-marketing dealmaking from 2016 to 2026, including:
- Trends in dealmaking by year
- Stage of development at the time of partnering
- Industry sector
- Therapy area
- Technology type
- Most active co-promotion and co-marketing dealmakers
- Leading transactions by disclosed value
- How shared commercialization strategies are evolving
Understand how co-promotion and co-marketing agreements are structured
Shared commercialization arrangements require clear allocation of commercial rights, responsibilities and economics between the parties.Depending on the transaction and available disclosure, users can investigate areas including:
- Co-promotion and co-marketing rights
- Geographic and territorial rights
- Exclusive and non-exclusive arrangements
- Sales and promotional responsibilities
- Marketing obligations
- Commercialization responsibilities
- Product positioning and branding
- Manufacturing and supply
- Revenue and profit-sharing mechanisms
- Royalties and other financial consideration
- Governance and decision-making
- Performance obligations
- Term and termination provisions
Benchmark commercial and financial terms
The report provides access to disclosed financial and commercial information associated with individual co-promotion and co-marketing transactions.Depending on the agreement, users can investigate:
- Upfront payments
- Milestones
- Revenue-sharing arrangements
- Profit-sharing arrangements
- Royalty provisions
- Commercial payments
- Other disclosed financial commitments
This provides real-world reference points for internal benchmarking, deal preparation and negotiation rather than relying on headline values or averages in isolation.
Identify leading co-promotion and co-marketing dealmakers
The report identifies the most active companies in co-promotion and co-marketing partnerships and provides transaction histories that enable users to investigate their previous activity.This can help users identify:
- Companies actively seeking commercial partners
- Prospective co-promotion and co-marketing partners
- Organizations with established commercial capabilities in relevant therapy areas
- Companies repeatedly using shared commercialization structures
- Competitors extending product reach through external partnerships
- Relevant precedent transactions involving comparable products or markets
Support commercial partner identification
For companies seeking a partner to help commercialize a product, historical co-promotion and co-marketing activity can provide valuable insight into potential counterparties.The report enables users to investigate which companies have previously:
- Promoted products alongside external partners
- Entered shared commercialization arrangements
- Taken commercial responsibility in specific therapeutic areas
- Worked within particular geographic markets
- Structured similar commercial relationships
Learn from real-world contract documents
Where publicly available, the report provides access to underlying contract documents for selected co-promotion and co-marketing transactions.These agreements can reveal substantially more detail than company announcements alone, enabling users to examine how partners have documented matters including:
- Commercial and promotional rights
- Territory
- Exclusivity
- Sales and marketing obligations
- Revenue and profit sharing
- Product supply
- Intellectual property and branding
- Governance
- Performance obligations
- Termination and continuing rights
Comprehensive co-promotion and co-marketing deal directory
The report includes a comprehensive directory of 523 co-promotion and co-marketing deals, providing a focused resource for identifying relevant precedent transactions and prospective partners.Deals can be investigated by:
- Company
- Stage of development
- Therapy area
- Technology type
- Contract availability
Who should use this report?
Business Development and Licensing teamsIdentify prospective commercial partners, comparable transactions and relevant co-commercialization structures.
Commercial Strategy teams
Understand how companies share promotional and commercialization responsibilities and extend product reach through partnerships.
Companies Seeking Commercial Partners
Identify organizations with demonstrated experience in co-promotion and co-marketing within relevant therapeutic and product areas.
Alliance Management teams
Examine how commercial responsibilities, governance and ongoing partner obligations have been structured across comparable agreements.
Market Access and Regional Commercial teams
Understand how partnerships are being used to extend commercial reach across markets and territories.
Competitive and Market Intelligence teams
Track how competitors are using shared commercialization relationships and identify active co-promotion dealmakers.
Legal and Transaction teams
Review publicly available contracts and precedent agreement structures to support transaction preparation and negotiation.
Turn market-wide commercial intelligence into company-specific insight
For qualifying customers, the analyst can also provide a Customized Executive Partnering Briefing alongside the report.The briefing applies the underlying co-promotion and co-marketing deal intelligence to the customer's own product, market or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective commercial partners, competitor activity, deal structures, commercial and financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in co-promotion and co-marketing dealmaking
Chapter 3 - Overview of co-promotion and co-marketing deal structure
Chapter 4 - Leading co-promotion and co-marketing deals
Chapter 5 - Top 25 most active co-promotion and co-marketing dealmakers
Chapter 6 - Co-promotion and co-marketing deals including contracts directory
Deal directory
TABLE OF FIGURES
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 1Cell.Ai
- 3D Medicines
- 4D Molecular Therapeutics
- 7D Surgical
- 10X Genomics
- Abbvie
- Abcam
- AbCellera Biologics
- Abingdon Health
- Abveris
- ACADIA Pharmaceuticals
- Accelerated Biosciences
- Acceleron Pharma
- Accent Therapeutics
- Accinov
- AccuGenomics
- ACEA Biosciences
- Acelrx Pharmaceuticals
- Acerus
- AC Immune
- ACIST Medical Systems
- Adaptimmune
- Adhera Therapeutics
- Advanced Analytical Technologies
- Advanced Biological Laboratories
- Aesculap
- AEterna Zentaris
- Affibody
- Affini-T Therapeutics
- Agena Bioscience
- Agenus Bio
- Agilent Technologies
- Aiforia Technologies
- Aignostics
- AiLife Diagnostics
- AirXpanders
- Ajinomoto
- Akeso Biopharma
- Akoya Biosciences
- Albany Molecular Research
- Aldeyra Therapeutics
- Alector
- Alexion Pharmaceuticals
- Alfasigma
- ALK-Abello
- Allcyte
- Allegis Pharmaceuticals
- Allergan
- Almirall
- Alnylam Pharmaceuticals
- Alphazyme
- Alyvant
- Amgen
- Amneal Pharmaceuticals
- AmplifyBio
- AMRA
- AMRA Medical
- Analytik Jena
- Andrew Alliance
- AnGes MG
- Apellis Pharmaceuticals
- Aplex Bio
- Applied Cells
- Applied DNA Sciences
- Applied Spectral Imaging
- Aratana Therapeutics
- Arbor Biotechnologies
- Arcellx
- ArcherDX
- Arcis Biotechnology
- Arcturus Therapeutics
- Arcus Biosciences
- Arcutis Biotherapeutics
- argenx
- Argonaut Manufacturing Services
- Aries Pharmaceuticals
- Arima Genomics
- Arkema
- Armune Bioscience
- ArQule
- Arrowhead Pharmaceuticals
- ARS Pharmaceuticals
- Arvinas
- Ascend Therapeutics
- Ascentage Pharma
- Assembly Biosciences
- Astellas Pharma
- Astex Pharmaceuticals
- AstraZeneca
- Aurigene Pharmaceutical Services
- Aurora Spine
- Automated Systems of Tacoma
- Avid Bioservices
- Avinger
- Axcend
- Aytu BioPharma
- Aziyo Biologics
- Basilea Pharmaceutica
- Bausch & Lomb
- Baxalta
- Bayer
- B Braun
- Beam Therapeutics
- Beckman Coulter
- Becton Dickinson
- BeiGene
- Beijing Minhai Biotechnology
- Belharra Therapeutics
- Belintra
- Benuvia Therapeutics
- Berlin Chemie
- BGI
- BGI Americas
- Bio-Rad Laboratories
- Bio-Techne
- BioAge Labs
- Biocartis
- biocrates
- Biodextris
- BioFluidica
- Biogen
- Biognosys
- Biological Industries
- BioNano Genomics
- BioNTech
- Biosero
- BioTek Instruments
- Blake Insomnia Therapeutics
- Bluebird Bio
- Blueprint Medicines
- Boehringer Ingelheim
- Bolt Biotherapeutics
- Bond Digital Health
- BOWA Medical
- Bracco Imaging
- BrainLAB
- BridgeBio Pharma
- Bristol-Myers Squibb
- Brooks Life Science Systems
- Bruker
- Burning Rock
- Cambrooke Therapeutics
- Capitainer
- Capsida Biotherapeutics
- Carl Zeiss
- CathWorks
- CC Pharma
- Celgene
- Cellectricon
- Cellenion
- Cellev8 Nutrition
- Cell Guidance Systems
- Cellular Dynamics International
- Cenra Healthcare
- Centogene
- Centrexion
- Century Therapeutics
- Cevec Pharmaceuticals
- Chime Biologics
- Cingulate
- Cipher Pharmaceuticals
- Clarify Medical
- Clario
- Clearbridge Biomedics
- CloudHealth Genomics
- COBO Technologies
- Codexis
- Complete Genomics
- CompleWare
- Concordia Pharmaceuticals
- Consortia Health
- Corazon
- CRISPR Therapeutics
- CrossLink Bioscience
- CSL
- CStone Pharmaceuticals
- Cue Biopharma
- Cullgen
- Cullinan Oncology
- Cumberland Pharmaceuticals
- CureVac
- Curi Bio
- Curio Genomics
- Cyclica
- Cynergi Health Partners
- CytomX Therapeutics
- CytoSorbents
- Daiichi Sankyo
- Delic
- Denali Therapeutics
- DePuy
- DexCom
- Diabetes Tools
- Dicerna Pharmaceuticals
- Discovery Life Sciences
- Domainex
- Dova Pharmaceuticals
- Dovetail Genomics
- Dren Bio
- DualityBio
- Eagle Genomics
- Eagle Pharmaceuticals
- EA Pharma
- eCential Robotics
- Echolight Medical
- Eckert & Ziegler
- ECMOHO
- eFFECTOR Therapeutics
- Egalet
- Eigen
- Eiger BioPharmaceuticals
- Eisai
- Elanco
- Elekta
- Element Biosciences
- Eli Lilly
- Elucidata
- Embolx
- EMC Pharma
- Empatica
- Emsere
- Enterome Bioscience
- EOS Imaging
- Epicypher
- Epizyme
- EPS International
- Eton Pharmaceuticals
- Everledger
- Evofem Biosciences
- Evosep
- eWellness Healthcare
- Exact Sciences
- Eyenovia
- Fabric Genomics
- Fate Therapeutics
- Ferring Pharmaceuticals
- Fidelis Research
- Fio
- FlowJo
- Fluidigm
- FMC
- Foghorn Therapeutics
- Fortelinea Software Systems
- Fosun International
- Fosun Pharmaceutical
- Freenome
- Fresenius Medical Care
- Fujifilm
- Fusion Pharmaceuticals
- G1 Therapeutics
- Galapagos
- GANZIMMUN Diagnostics
- GE Healthcare
- Gencove
- Genentech
- Genetron Health
- Genialis
- Genmab
- GenNext Technologies
- Genoox
- Genosity
- GenScript Biotech
- Genzyme
- George Clinical
- Germfree
- Getein Biotech
- Gilead Sciences
- Ginkgo BioWorks
- Glenmark Pharmaceuticals
- Goldfinch Bio
- Great Bay Bio
- GSK
- GT Research
- Guerbet
- Guohong Guokang (Beijing) Health Technology Development
- H3 Biomedicine
- HalioDx
- Halyard Health
- Hamamatsu Photonics
- Hamilton Company
- Hanmi Pharmaceutical
- Harbin Pharmaceutical Group
- Harbour Antibodies
- HD Biosciences
- HealthTech Connex
- HeartGenetics
- Heartseed
- Helius Medical Technologies
- Helsinn Healthcare
- Helsinn Therapeutics
- Henkel
- Heron Therapeutics
- High Beauty
- Hitachi Medical Systems Europe
- Hologic
- Hormosan Pharma GmbH
- Hovione
- Iagnosis
- IBA
- Ibex Medical Analytics
- IBM Watson Health
- iCAD
- Icagen
- Iconic Therapeutics
- IDbyDNA
- Idorsia
- Igentify
- Illumina
- ImaBiotech
- Immatics Biotechnologies
- Immunicon
- ImmunityBio
- ImmunoGen
- Immunomedics
- Incyte
- Indee Labs
- Indegene Lifesystems
- Indica Labs
- Infinitt
- Innara Health
- Innate Pharma
- Innovent Biologics
- INOVIQ
- Inscopix
- Insitro
- Inspirion Delivery Sciences
- Inspirna
- Intabio
- Integrated DNA Technologies
- Intellia Therapeutics
- Ionis Pharmaceuticals
- IonOpticks
- IROA Technologies
- Ironwood Pharmaceuticals
- ISS Solutions
- iTeos Therapeutics
- Janssen Biotech
- Janssen Pharmaceuticals
- Jiangsu Alphamab
- Jiangsu Carephar Pharmaceutical
- Jiangsu Chia Tai Tianqing Pharmaceutical
- Jiangsu Hengrui Pharmaceuticals
- Johnson & Johnson
- Jointpoint
- Joylux
- Jumpcode Genomics
- K2M
- Kailos Genetics
- Kaleo
- Karl Storz
- Kerma Medical Products
- Kite Pharma
- Konica Minolta
- Kowa Pharmaceuticals America
- KSQ Therapeutics
- KVP International
- Kyorin Pharmaceutical
- Kyowa Hakko Kirin
- Kyverna Therapeutics
- L1 Systems
- Leica Biosystems
- Leica Microsystems
- LEO Pharma
- Lexington Medical
- LG Life Sciences
- Lifecore Biomedical
- Life Genomics AB
- Lord Global
- Loxo Oncology
- LumiraDx
- Lunaphore
- Lundbeck
- Luqa Pharmaceuticals
- Luxcel Biosciences
- Lygos
- Mabtech
- Macherey-Nagel
- Macrogenics
- Magnolia Medical
- Mainz Biomed
- Malvern Instruments
- Manchester BIOGEL
- MannKind Biopharmaceuticals
- Mazor Robotics
- MedHelp
- Medical Enterprises Distribution
- Medicines360
- Medigus
- MedImmune
- Medis
- Medovate
- Medtronic
- Meihua International Medical Technologies
- MEI Pharma
- MeMed
- Menarini
- Menarini Silicon Biosystems
- Merck and Co
- Merck KGaA
- Mersana Therapeutics
- Mesoblast
- Metagenomi
- Metavant
- MGI Tech
- Microsaic Systems
- Microsoft
- Midatech Pharma
- Mikart
- Miltenyi Biotec
- Mimetas
- Mission Bio
- Mitsubishi Tanabe Pharma
- Mochida Pharmaceutical
- Moderna
- Molecular Instruments
- Molnlycke Health Care
- Momenta Pharmaceuticals
- Morphic Therapeutic
- MorphoSys
- MRM Proteomics
- MSD
- MYOS
- Myovant Sciences
- Nanion
- NanoMosaic
- NanoString Technologies
- NantKwest
- Napo Pharmaceuticals
- Ncardia
- Neotope
- NeraCare
- Nestle Health Science
- NeuPath Health
- Neurexpert
- Neuro3 Therapeutics
- Neurocrine Biosciences
- Newomics
- New York Center for Nanomedicine Research
- Nexa3D
- Nexel
- Next&Bio
- NGeneBio
- Nkarta Therapeutics
- Noldus Information Technology
- NovaBay Pharmaceuticals
- Novartis
- Novogene
- Novoheart
- Novo Nordisk
- Nrgene
- nRichDX
- Nucleai
- Numab
- Nurix Therapeutics
- nView Medical
- ODI Pharma
- Olympus
- Olympus Medical Systems
- OncoCyte
- OncoDNA
- OncoSec Medical
- ONK Therapeutics
- Ono Pharmaceutical
- OpGen
- OptiNose
- Orapharma
- OraSure Technologies
- Orgenesis
- Orion
- Ortho-Clinical Diagnostics
- Orthofix Medical
- Osteopore International
- Otonomy
- Otsuka
- Oxford BioMedica
- Oxford Gene Technology
- Pacific Biosciences
- Pacira Biosciences
- Paige
- Paragon Bioservices
- Pearsanta
- PeptiGrowth
- Personalis
- Pfizer
- Pharmaceutics International
- Phil
- Pierian
- PierianDx
- Pieris Pharmaceuticals
- Pillar Biosciences
- Piramal
- Pivot Pharmaceuticals
- Pluristyx
- Poxel
- Precision BioSciences
- PrecisionLife
- Precision NeuroMed
- Predicine
- Prelude Therapeutics
- Prepaire Labs
- Pressure BioSciences
- Prevail Therapeutics
- Promega
- Protagonist Therapeutics
- Protea Biosciences
- Protean BioDiagnostics
- Protein Metrics
- Proteos
- Proteovant Therapeutics
- Prothena
- ProTom International
- Provention Bio
- Prxcision
- PSI (Population Services International)
- Purdue Pharma
- PureHoney Technologies
- Pure Pharmaceuticals
- QED Therapeutics
- QIAGEN
- QMed Innovations
- Quanta
- QuantumCyte
- Radformation
- Radius Health
- Rainbow Scientific
- Rakuten Medical
- Recludix Pharma
- RedHill Biopharma
- RefleXion Medical
- Regeneron Pharmaceuticals
- Regenxbio
- Relay Medical
- Relay Therapeutics
- Repare Therapeutics
- Resonant Specific Technologies
- Revolution Medicines
- Rigel Pharmaceuticals
- RNAV8
- Roche
- Roche Diagnostics
- Rockwell Medical
- Roivant Sciences
- Royal Philips Electronics
- Rubicon Genomics
- S2 Genomics
- Sage Therapeutics
- Sai Life Sciences
- Sajo Consulting
- Salix Pharmaceuticals
- Sanofi
- Sanofi-Aventis
- Sanofi US Services
- Santen Pharmaceutical
- Sapio Sciences
- Sarepta Therapeutics
- Sato Pharmaceutical
- Schrodinger
- Sciex
- Scorpion Therapeutics
- Scribe Therapeutics
- Seagen
- SeaSpine
- Seattle Genetics
- Seer
- Senshinkai Eye Institute
- Seren Pharmaceuticals
- Seres Therapeutics
- Shimadzu
- Shionogi
- SHL Medical
- Siemens Healthineers
- Silicon Biosystems
- Simcere Pharmaceutical
- Sirona Dx
- Sirtex Medical
- SK Biopharmaceuticals
- Solesis
- Solid Biosciences
- Sona Nanotech
- Sonoma BioTherapeutics
- Sonoma Pharmaceuticals
- SOPHiA Genetics
- Sosei
- SoTAX
- SparingVision
- Spineart
- SpiroChem
- Staar Surgical Co
- Stealth BioTherapeutics
- Stemmatters
- Stoke Therapeutics
- Stone Diagnostics
- StrideBio
- Stryker
- STU
- Sumitomo Dainippon Pharma
- Summit Therapeutics
- Sunovion Pharmaceuticals
- Sun Pharmaceutical
- SurGenTec
- Surgical Planning Associates
- Sutro Biopharma
- Swift Biosciences
- Swixx Biopharma
- Synaptive Medical
- Syndax Pharmaceuticals
- T2 Biosystems
- Tagomics
- Taiho
- Taisho Pharmaceutical
- Takeda Pharmaceutical
- Tango Therapeutics
- Teijin
- Telix Pharmaceuticals
- Tempus
- Terumo
- Terumo Blood and Cell Technologies
- Tetraphase Pharmaceuticals
- Teva Pharmaceutical Industries
- Theravance
- Thermo Fisher Scientific
- TheWell Bioscience
- Tilak Healthcare
- Tilray
- Tissue Analytics
- Titan Pharmaceuticals
- Tolmar
- TOMI Environmental Solutions
- TRACON Pharmaceuticals
- Tractebel
- TransMIT
- Trovita Health Science
- TTP LabTech
- Twist Bioscience
- Tyme Technologies
- UCB
- Ultivue
- Ultragenyx Pharmaceuticals
- Uni-Bio Science
- Unisys
- Universal Cells
- Urovant Sciences
- US WorldMeds
- Varian Medical Systems
- Verity Pharmaceuticals
- Vertex Pharmaceuticals
- Vertice Pharma
- Vida Diagnostics
- Vifor Pharma
- Vipergen
- Vir Biotechnology
- Virscidian
- Visiopharm
- Vivos Therapeutics
- VolitionRX
- Voyager Therapeutics
- Wasatch BioLabs
- Waters Corporation
- WAVE Life Sciences
- Windsong Radiology
- Wyatt Technology
- Xellia Pharmaceuticals
- Xencor
- Yamaha Motor
- ZAI Laboratory
- Zealand Pharma
- Zerion Pharma
- Ziath
- Zimmer Biomet
- Zylox Tonbridge Medical Technology Co Ltd
- Zymeworks
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
